Research Article

Protection of hamsters against experimental mumps virus (MuV) infection by antibodies raised against the MuV surface glycoproteins expressed from recombinant vaccinia virus vectors

Journal of General Virology 1995; 76(2):421 · https://doi.org/10.1099/0022-1317-76-2-421

View at publisher PubMed

Abstract

The fusion (F) and haemagglutininneuraminidase (HN) glycoproteins of mumps virus (MuV) have been produced in CV1 cells via vaccinia virus recombinants. Recombinant proteins accumulated in infected cells and were glycosylated. Upon reduction, the F protein product was completely converted into its subunits. Hamsters infected with vaccinia recombinants expressing either the F or HN proteins produced antibodies recognizing MuV antigens and neutralizing MuV infectivity in vitro. These antibodies provided protection against MuV-induced encephalitis in newborn hamsters.

* Author for correspondence. Fax +32 67 287777. e-mail shouard@ulb.ac.be